Ofloxacin |
Floxin |
Article: Ofloxacin
| Image:Ofloxacin.png | |
| Ofloxacin | |
| Systematic (IUPAC) name | |
| (+/-)-9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)- 7-oxo-7H-pyrido [1,2,3-de]-1, 4-benzoxazine-6-carboxylic acid | |
| Identifiers | |
| CAS number | 82419-36-1 |
| ATC code | J01MA01 J01MA02, J01MA12, S01AX11, S01AX13, S01AX19, S03AA07 |
| PubChem | 4583 |
| DrugBank | APRD00502 |
| Chemical data | |
| Formula | C18H20FN3O4 |
| Mol. weight | 361.368 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 32% |
| Metabolism | ? |
| Half life | 9 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | C (US) |
| Legal status | Perscription Only (US) |
| Routes | topical (ear drops) |
Ofloxacin sold under the brand name Floxin in the US. It is a quinolone antibiotic. Ofloxacin is the racemic mixture of the chiral compound. The biologically active enantiomer is sold separately under the name of levofloxacin. It is an alternative treatment to ciprofloxacin for anthrax.

Not Signed In -


